- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00825513
Safety and Effectiveness of the Akreos Toric Intraocular Lens.
March 19, 2013 updated by: Bausch & Lomb Incorporated
Monocular Study to Evaluate the Safety and Effectiveness of the Akreos™ Toric IOL When Used to Correct Primary Aphakia With the Reduction of Astigmatism
The purpose of this study is to evaluate the safety and effectiveness of the Akreos Toric IOL following cataract surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
198
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Umea, Sweden, SE-901 85
- Dept. of Clinical Sciences/ Ophthalmology Umea University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects must be willing and able to provide written consent on the EC approved Informed Consent form.
- Subjects must require a lens power from 15 to 30 diopters.
Exclusion Criteria:
- Subjects with any anterior segment pathology for which extracapsular phacoemulsification cataract surgery would be contraindicated.
- Subjects with corneal pathology potentially affecting topography.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Akreos Toric
Akreos Toric Intraocular Lens
|
Lens implant following cataract surgery
|
|
Active Comparator: Akreos Advanced
Akreos Advanced Optics Aspheric Intraocular Lens (Akreos AO)
|
Lens implant following cataract surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Reduction of cylinder, Lens axis misalignment as determined by a photographic method.
Time Frame: 32 months
|
32 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Lens misalignment as determined by postoperative manifest refraction and vector analysis.
Time Frame: 32 months
|
32 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Gabriele Brenger, Bausch & Lomb Incorporated
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
September 1, 2012
Study Registration Dates
First Submitted
January 16, 2009
First Submitted That Met QC Criteria
January 16, 2009
First Posted (Estimate)
January 21, 2009
Study Record Updates
Last Update Posted (Estimate)
March 25, 2013
Last Update Submitted That Met QC Criteria
March 19, 2013
Last Verified
March 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 566
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Colvard Kandavel Eye CenterEnrolling by invitationCataract | Cataract Bilateral | Cataract Surgery | Cataract (Post-operative Cataract Surgery Follow-up)United States
-
Matthew RauenNot yet recruitingNuclear Cataract | Cataract Surgery Anesthesia | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Züleyha SönmezAtaturk UniversityActive, not recruitingCataract Surgery | Cataract Patients | Cataract After SurgeryTurkey (Türkiye)
-
Stanford UniversityEnrolling by invitationIntraocular Lens | Cataract Extraction | Cataract Surgery | Eye Disorders | Cataract and IOL Surgery | Cataract Surgery ExperienceUnited States
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Seva Canada SocietyPragyaan Sustainable Health Outcomes Foundation; Sadgura Netra ChikitsalayaNot yet recruitingCataract (Post-operative Cataract Surgery Follow-up)
-
Nicole Fram M.D.RecruitingCataract Bilateral | Nuclear Sclerosis of the Lens | Phacoemulsification Cataract SurgeryUnited States
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
Clinical Trials on Akreos Toric IOL
-
University of Sao PauloCompletedLens Implantation, IntraocularBrazil
-
Bausch & Lomb IncorporatedCompletedCataract | AphakiaGermany
-
Ifocus OyeklinikkAlcon ResearchCompletedCataract and IOL SurgeryNorway
-
Johnson & Johnson Surgical Vision, Inc.CompletedCataract | Corneal AstigmatismUnited States
-
University of PlymouthBMI Southend HospitalUnknownCataractUnited Kingdom
-
Alcon ResearchCompleted
-
Carl Zeiss Meditec AGtargomedGmbHNot yet recruiting
-
Alcon ResearchQueensland University of TechnologyCompleted
-
Alcon ResearchWithdrawn